Dealmaking

ArchiMed’s Denis Ribon details €1.5bn fund deployment plans as AI reshapes healthcare

In September, ArchiMed announced the final closing of its fourth small-cap healthcare buyout fund, MED IV, exceeding its original target of €1.2 billion.

Permira mulls $3.5bn Octus sale to London Stock Exchange Group; Palliser raises further concerns over CVC, GBL bid for Italy’s Recordati

Palliser Capital, a shareholder of Recordati, has confirmed it does not support the recent offer of €53 per share from CVC and GBL.

ATL Partners reveals scaling plans for Precise Aerospace & Defense; LMP’s Brad Armstrong shares SRS Acquiom expansion strategy

PE Hub caught up with ATL partner Michael Kramer to discuss firm’s thesis and the opportunities the firm sees for its newly-formed formed Precise Aerospace & Defense platform; Rhône agrees to sell Paragon Films to Atlantic Ridge Capital and Grafine Partners.

Exclusive: ATL Partners forms Precise Aerospace & Defense platform

The firm also announced Precise A&D’s inaugural acquisition, of Precise Metal Products from affiliates of Staple Street Capital.

Aurelius eyes industrial AI with Nokia’s Enterprise Campus Edge carve-out; Riverside’s Dastex makes seventh add-on

Nokia's ECE serves nearly 900 customers worldwide, spanning manufacturing, mining, logistics, airports, ports and power generation.

Orlando Bravo: AI is ‘reshaping’ investment research; Tigertail’s HVAC platform acquires Wisconsin business

Tigertail launched in 2024 with initial backers including family offices and industry executives.

Data snapshot: Dry powder builds up in post-2021 PE funds

Private equity funds raised in recent years hold far more undeployed capital than earlier vintages at the same stage in their life, PEI Group data shows.

Orlando Bravo: BlueMatrix 'will become the standard' for investment research after Aiera add-on

'AI is reshaping how investment research is created and consumed,' Bravo tells PE Hub.

Adelis, Aspirity bet on Nordic businesses; Ambienta, Omni Partners feature in new hire round up

Omni Partners announced it has appointed Elliot Tahmasebi as a partner in London to strengthen its sourcing and execution in the lower mid-market.

Apollo, Kohlberg, Montagu pursue surgical equipment providers; Radiopharma boom aids Trilantic North America’s $945m SOFIE Biosciences exit

Barriers to entry are an attractive driver for private equity firms that already have a sizeable presence in a sector, and we discuss the influence in two healthcare markets: surgical equipment providers and radiopharmaceuticals.